Quantifying the Renal Impact of [ 177 Lu]Lu-PSMA-617: A Longitudinal Analysis of Real-World Data from the LUMEN Registry
Journal of Nuclear Medicine · 2026
DOI: 10.2967/jnumed.125.271077 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Nuclear Medicine, 2026. Verfasst von Thomas Büttner und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology and Pediatric Urology, University Hospital Bonn, Bonn, Germany; and thomas.buettner@ukbonn.de. Hauptthemen laut MEDLINE: Dipeptides, Heterocyclic Compounds, 1-Ring, Registries, Lutetium. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
This study aimed to clarify the renal safety of [177Lu]Lu-PSMA-617 for metastatic castration-resistant prostate cancer (mCRPC), addressing emerging reports of nephrotoxicity.
Methods
We retrospectively analyzed patients with mCRPC from the real-world LUMEN registry who received 3 or more cycles of [177Lu]Lu-PSMA-617. The endpoint was the change in estimated glomerular filtration rate (eGFR) over 24 mo, assessed using linear mixed-effects models.
Results
Analysis of 261 patients revealed a modest average decline in eGFR of -0.15 mL/min/1.73 m2 per month (95% CI, -0.25 to -0.05; P = 0.005), translating to -1.80 mL/min/1.73 m2 per year (95% CI, -3.03 to -0.57). The rate of loss accelerated by approximately -0.1 per year per additional gigabecquerel of administered activity (95% CI, -0.18 to -0.01; P = 0.028). Conclusion: [177Lu]Lu-PSMA-617 is associated with a slight long-term average decline in eGFR. Although this is unlikely to be clinically relevant for late-stage mCRPC, the cumulative dose effect warrants careful monitoring in earlier disease stages.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology and Pediatric Urology, University Hospital Bonn, Bonn, Germany; and thomas.buettner@ukbonn.de.
- Department of Urology and Pediatric Urology, University Hospital Bonn, Bonn, Germany; and.
- Department of Nuclear Medicine, University Hospital Bonn, Bonn, Germany.
Zitieren
APA
Büttner, T., Hoffmann, C., Essler, M., Gärtner, F., Kreppel, B., Küppers, J., Ritter, M., Fritzsche, L., Marinova, M., & Krausewitz, P. (2026). Quantifying the Renal Impact of [ 177 Lu]Lu-PSMA-617: A Longitudinal Analysis of Real-World Data from the LUMEN Registry. Journal of Nuclear Medicine. https://doi.org/10.2967/jnumed.125.271077
Vancouver
Büttner T, Hoffmann C, Essler M, Gärtner F, Kreppel B, Küppers J, et al. Quantifying the Renal Impact of [ 177 Lu]Lu-PSMA-617: A Longitudinal Analysis of Real-World Data from the LUMEN Registry. Journal of Nuclear Medicine. 2026. doi:10.2967/jnumed.125.271077
BibTeX
@article{Bttner2026,
author = {Büttner, Thomas and Hoffmann, Christian and Essler, Markus and Gärtner, Florian and Kreppel, Barbara and Küppers, Jim and Ritter, Manuel and Fritzsche, Leander and Marinova, Milka and Krausewitz, Philipp},
title = {Quantifying the Renal Impact of [ 177 Lu]Lu-PSMA-617: A Longitudinal Analysis of Real-World Data from the LUMEN Registry},
journal = {Journal of Nuclear Medicine},
year = {2026},
doi = {10.2967/jnumed.125.271077}
}
EUVIMED